Clinical Trials

Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title Phase Last Update

A Phase I/II, Dose Finding and Optimization Study of [Lu-177]Lu-NeoB in Combination with Capecitabine in Patients with GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination with a CDK4/6 Inhibitor. (NeoB-Cap1)

Phase 1

Last update: July 24

Phase 1 July 24

Abemaciclib Before Lu-177-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer (UPLIFT)

Phase 1

Last update: July 24

Phase 1 July 24

A Study of Lu-177-FAP-2286 in Advanced Solid Tumors (LuMIERE)

Phase 1

Last update: July 24

Phase 1 July 24

Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Phase 1

Last update: July 24

Phase 1 July 24

Comparing Retreatment of Lu-177-DOTATATE PRRT versus the Usual Treatment in Patients with Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Phase 2

Last update: July 22

Phase 2 July 22

Pluvicto Real-world Investigation in Survival in Metastatic CRPC (PRISM)

N/A

Last update: July 22

N/A July 22

A Phase 1 Study of Lu-177-IM-3050 in Participants with Advanced Cancer

Early Phase 1

Last update: July 21

Early Phase 1 July 21

Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer (GUARD-QUANTUM)

Phase 2

Last update: July 21

Phase 2 July 21

The Study of Lu-177-TLX591 Plus SOC versus SOC Alone in Patients with mCRPC (ProstACT Global)

Phase 3

Last update: July 21

Phase 3 July 21

Low-Count Quantitative SPECT for Men Treated with Radium-223

N/A

Last update: July 21

N/A July 21